Moderna started development on a booster to the company’s Covid-19 vaccine, which is hoped to work against the recently discovered (and more transmissible) SARS-CoV-2 variant from South Africa.

This white paper from Abbott examines a cross-section of the global healthcare system leveraging primary research with 1,400+ respondents including patients, physicians, and administrators.

Shionogi & Co. is planning clinical trials by year-end 2020 for what may be one of Japan’s first domestically produced Covid-19 vaccines to reach the market, as the globe races to secure enough doses to battle the pandemic.

Outcome Health announced the launch of Who Saves Me?, a campaign to bring awareness to the overwhelming percentage of physicians who quietly suffer from burnout and mental health struggles. 

BioSpace reviews some of the more interesting recently published scientific studies, including whether the Covid-19 virus relieve pain.

Researchers from Aarhus University in Denmark published research indicating that Parkinson’s disease is actually two types of the disease.

Recently published scientific studies include research suggesting why Covid-19 is deadlier in the elderly and men.

There is quite a bit of evidence that Covid-19 negatively affects cardiac muscle.

GlaxoSmithKline opened a new $13 million research hub in London focused on artificial intelligence.

Nearly 300,000 Americans could be dead from Covid-19 by Dec. 1, University of Washington health experts forecast, although they said 70,000 lives could be saved if people were scrupulous about wearing masks.